To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.
This is a protocol.
Capecitabine for ER-positive versus ER-negative breast cancer
You may also be interested in:
- A meta-analysis of clinical trials comparing taxane containing chemotherapy with non-taxane containing chemotherapy for women following surgery for early breast cancer
- High-dose chemotherapy and bone marrow or stem cell transplantation for early poor prognosis breast cancer using a woman's own cells (autologous)
- Sequencing of chemotherapy and radiotherapy for women following surgery for early breast cancer
- Combination (several drugs at the same time) versus sequential chemotherapy (same drugs given one after the other) for metastatic breast cancer
- Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
Health topics: